Advertisement

Topics

Galapagos nv Company Profile

11:27 EDT 25th September 2017 | BioPortfolio

Galapagos was founded in 1999 as a joint venture between Crucell (formerly IntroGene) and Tibotec. From the start, Galapagos has operated a hybrid business model, combining internal discovery programs with service activities. The joint venture operated until 2002 when the Company raised €23.4 million in a private placement. In May 2005, the Company raised €22.4 million through its initial public offering on the Euronext Brussels (Ticker symbol: GLPG) and Euronext Amsterdam (GLPGA) stock exchanges. In October 2005, Galapagos acquired BioFocus, a drug discovery company based in Saffron Walden, UK, through an all share offer, giving BioFocus shareholders a 29% state holding in the enlarged Company. On October 20, 2005 Galapagos started trading on the Alternative Investment Market of the London Stock exchange (Ticker symbol: GLPG). On June 13, 2006 Galapagos announced the acquisition of the drug discovery operations of Discovery Partners International, forming the new drug discovery division called BioFocus DPI.

Location

Industriepark Mechelen Noord Generaal De Wittelaan L11 A3
Mechelen
B-2800
Belgium

Contact

Phone: 32 15 34 29 00
Fax: 32 15 34 29 01
Email: bd@glpg.com


News Articles [51 Associated News Articles listed on BioPortfolio]

Galapagos and Gilead Launch the Fifth New Trial for Filgotinib this Year

With the addition of uveitis, Galapagos and Gilead are raising to 10 the number of indications in filgotinib’s clinical pipeline. Galapagos and Gilead clearly have big expectations for filgotini...

How the Galapagos cormorant lost its ability to fly

The flightless cormorant is one of a diverse array of animals that live on the Galapagos Islands, which piqued Charles Darwin's scientific curiosity in the 1830s. He hypothesized that altered evolutio...

Galapagos posts impressive top-line data in lung disease

Galapagos is currently working on an agent called GLPG1690, an inhibitor of autotaxin for use in patients…

Galapagos NV: Galapagos to hold Annual R&D Update 2017 on 20 June

Mechelen, Belgium; 17 May 2017; 7.30 CET - Galapagos NV (Euronext & NASDAQ: GLPG) announces it will hold its Annual R&D Update 2017 on 20 June at 8 AM EDT at the Yale Club in New York City. This e...

#news #biotech Galapagos to take IPF drug into late-stage trial after phase 2 win

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Galapagos to take IPF drug into late-stage trial after phase 2 win .Belgian b...

Galapagos reports positive results from pulmonary fibrosis study

Galapagos announced positive results from a Phase IIa clinical trial of its selective autotaxin inhibitor GLPG1690 for patien -More- 

Galapagos NV: Seven abstracts on filgotinib accepted by EULAR 2017

Mechelen, Belgium; 15 May 2017, 22.00 CET - Galapagos NV (Euronext & NASDAQ: GLPG) announces the acceptance of seven abstracts from several clinical and pre-clinical studies with the investigation...

Galapagos announces phase IIa results with GLPG1690 in IPF patients

Galapagos NV has announced positive topline results with its autotaxin inhibitor GLPG1690 in patients with idiopathic pulmonary fibrosis (IPF) in the FLORA phase IIa trial. FLORA was an exploratory, ...

Drugs and Medications [0 Results]

None

PubMed Articles [5 Associated PubMed Articles listed on BioPortfolio]

Plant species dispersed by Galapagos tortoises surf the wave of habitat suitability under anthropogenic climate change.

Native biodiversity on the Galapagos Archipelago is severely threatened by invasive alien species. On Santa Cruz Island, the abundance of introduced plant species is low in the arid lowlands of the Ga...

Residency and movement patterns of an apex predatory shark (Galeocerdo cuvier) at the Galapagos Marine Reserve.

The potential effectiveness of marine protected areas (MPAs) as a conservation tool for large sharks has been questioned due to the limited spatial extent of most MPAs in contrast to the complex life ...

Benefits of the destinations, not costs of the journeys, shape partial migration patterns.

1.The reasons that lead some animals to seasonally migrate, and others to remain in the same area year-round, are poorly understood. Associations between traits, such as body size, and migration provi...

Alien species pathways to the Galapagos Islands, Ecuador.

Alien species, one of the biggest threats to natural ecosystems worldwide, are of particular concern for oceanic archipelagos such as Galápagos. To enable more effective management of alien species, ...

Passerine morphology: external measurements of ca. one-quarter of passerine bird species.

Studies of community organization and clade diversification that include functional traits have become an important component of the analysis of ecological and evolved systems. Such studies frequently...

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Galapagos nv

Galapagos was founded in 1999 as a joint venture between Crucell (formerly IntroGene) and Tibotec. From the start, Galapagos has operated a hybrid business model, combining internal discovery programs...

Discovery Partners International

Discovery Partners recently completed the sale of all of the stock of Discovery Partners’ operating subsidiaries and all of Discovery Partners’ material operating assets pursuant to a stock and as...

Galapagos

We are a genomics based drug discovery company, that has drug discovery programs based on proprietary disease modifying drug targets. Our vision is to bring novel drugs to the market in selected disea...

More Information about "Galapagos nv" on BioPortfolio

We have published hundreds of Galapagos nv news stories on BioPortfolio along with dozens of Galapagos nv Clinical Trials and PubMed Articles about Galapagos nv for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Galapagos nv Companies in our database. You can also find out about relevant Galapagos nv Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record